Related Experiment Video

Updated: May 6, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

17.1K

[Frequency and characteristics of granulomas in 368 pediatric patients with Crohn's disease]

Katalin Eszter Müller1, Péter László Lakatos, Mária Papp

  • 1Semmelweis Egyetem, Általános Orvostudományi Kar I. Gyermekgyógyászati Klinika Budapest Bókay u. 53. 1083.

Orvosi Hetilap
|October 22, 2013
PubMed

Insights

Epithelioid granulomas appear in 31.4% of pediatric Crohn's disease cases. Their presence does not significantly alter disease characteristics or treatment needs, but multiple biopsies are crucial for diagnosis.

Area of Science:

  • Gastroenterology
  • Pediatric Inflammatory Bowel Disease
  • Histopathology

Context:

  • Epithelioid granulomas are key histological markers for Crohn's disease (CD).
  • The precise role of granulomas in CD pathogenesis and clinical presentation remains incompletely understood.
  • Distinguishing CD from other inflammatory bowel diseases (IBD) often relies on identifying granulomas.

Purpose:

  • To determine the frequency of granulomas in pediatric Crohn's disease.
  • To investigate the association between granuloma presence and clinical features in children with CD.
  • To evaluate the diagnostic contribution of granulomas in specific gastrointestinal locations.

Summary:

  • A study of 368 children with CD found granulomas in 31.4% at diagnosis.
  • No significant differences were observed in disease location, behavior, activity, or initial treatment needs between patients with and without granulomas.
  • Isolated granulomas were found in the upper GI tract (2.5%) and terminal ileum (5%), aiding diagnosis in some cases.

Impact:

  • Highlights the importance of comprehensive biopsies from multiple sites for accurate pediatric CD diagnosis.
  • Suggests that while granulomas are common, they may not be the sole determinant of disease behavior or treatment trajectory.
  • Provides valuable data on granuloma frequency and clinical correlation in a pediatric CD cohort.
Abstract

Keywords:
Crohn-betegségCrohn’s diseasegranulomagyermekkorigyulladásos bélbetegségpediatric inflammatory bowel diseaseregistryregiszter

More Related Videos

Rapid Magnetic-microbead Method for Efficient Purification of Low-density Neutrophils08:14

Rapid Magnetic-microbead Method for Efficient Purification of Low-density Neutrophils

Published on: November 11, 2025

629
Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

8.8K

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
51
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
703